Osteoporosis

Sudipa Sarkar, MD, MSCI, Todd T. Brown, M.D., Ph.D.
Osteoporosis is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

CLINICAL

  • Osteoporosis in people with HIV (PWH) is 3-4 times more common than in the general population.
  • Increased prevalence may be due in part to high prevalence of risk factors, including low body weight, hypogonadism, smoking, alcohol use, low vitamin D levels, and steroid use.
  • The role of ART is unclear. ART initiation is associated with 2-3% loss in bone mineral density (BMD) in the first 6 months in multiple studies. It is unclear if this is due to medication effect or a by-product of viral suppression and/or immune reconstitution. Longitudinal studies of treated PWH generally show stable BMD over time.
  • Bone loss with initiation of TDF-FTC is more pronounced than with ABC-3TC.[7]
  • BMD explains approximately 50% of fracture risk in general population, perhaps less in PWH. Bone quality is also important but is difficult to assess.
  • Fracture risk in PWH not adequately assessed to date.[6]

-- To view the remaining sections of this topic, please or --

CLINICAL

  • Osteoporosis in people with HIV (PWH) is 3-4 times more common than in the general population.
  • Increased prevalence may be due in part to high prevalence of risk factors, including low body weight, hypogonadism, smoking, alcohol use, low vitamin D levels, and steroid use.
  • The role of ART is unclear. ART initiation is associated with 2-3% loss in bone mineral density (BMD) in the first 6 months in multiple studies. It is unclear if this is due to medication effect or a by-product of viral suppression and/or immune reconstitution. Longitudinal studies of treated PWH generally show stable BMD over time.
  • Bone loss with initiation of TDF-FTC is more pronounced than with ABC-3TC.[7]
  • BMD explains approximately 50% of fracture risk in general population, perhaps less in PWH. Bone quality is also important but is difficult to assess.
  • Fracture risk in PWH not adequately assessed to date.[6]

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: January 13, 2021